Drug-induced myocarditis: a real-world pharmacovigilance study using the FDA adverse event reporting system database
Our findings suggest a potential risk of drug-induced myocarditis associated with various medications. Close monitoring for signs and symptoms of myocarditis is crucial, especially in patients with risk factors or those receiving these drugs. Further investigations are warranted to establish causality and identify risk factors.
Authors
- Jinyi Tao
- Zhiwen Fu (ORCID: https://orcid.org/0000-0002-0635-1368)
- Yunxiang Zhong
- Zhiping Li (ORCID: https://orcid.org/0000-0001-6194-023X)
- Jiao Yuan (ORCID: https://orcid.org/0000-0002-3925-8469)
Institutions
- Union Hospital (HK)
- Dongguan People’s Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1080/14740338.2024.2416933
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.35